Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qinxiang Qingjie oral liquid versus oseltamivir for pediatric influenza
ChiCTR1900021060Phase 4Not yet recruiting
- Sponsor
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
- Start
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Qinxiang Qingjie Oral Liquid and oseltamivir in influenza (2 arms), sponsored by First Teaching Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoint: Clinical recovery time. Planned start Feb 2019; status: not yet recruiting.
02
Drugs
Qinxiang Qingjie Oral Liquidoseltamivir
03
Conditions
influenza
Beyond the preview
Go deeper on ChiCTR1900021060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900021060.